Case series:Apatinib Mesylas combine with Xiaoyan Tang

2 trials

Sponsors

First Affilicated Hospital of Tianjin University of Traditional Chinese Medicine

Conditions

Lung Canceradvanced gastrointestinal cancer

Unknown Phase

Apatinib Mesylas combine with Xiaoyan Tang of advanced non-squamous, non-small cell lung cancer patients in an open and exploratory research

RecruitingChiCTR-OOC-16008238

First Affilicated Hospital of Tianjin University of Traditional Chinese MedicineLung Cancer

Start: 2016-04-10Updated: 2017-04-18

Apatinib Mesylas combine with Xiaoyan Tang of advanced gastrointestinal cancer patients in an open and exploratory research

RecruitingChiCTR-OOC-16008234

First Affilicated Hospital of Tianjin University of Traditional Chinese Medicineadvanced gastrointestinal cancer

Start: 2016-04-10Updated: 2017-04-18